Two pharmaceutical enterprises are listed in the top 100 private enterprises list of Guangdong Province in 2019

[industry trends of pharmaceutical network] on November 28, the list of "top 100 private enterprises in Guangdong Province 2019" was released, and the revenue threshold of enterprises on the list in 2019 exceeded 10 billion yuan Among them, in 2018, there were 9 enterprises with an operating revenue of more than 100 billion yuan, the same as the previous year; 57 enterprises with an operating revenue of more than 20 billion yuan In terms of industry distribution, there are 42 manufacturing enterprises, 13 wholesale and retail enterprises and 13 real estate enterprises In addition, in the pharmaceutical manufacturing industry, there are two pharmaceutical enterprises selected, namely, Haiwang Group and Kangmei pharmaceutical It is reported that the list was released to set a benchmark for private enterprises, encourage Guangdong private enterprises to have firm confidence in development, dare to reform and innovate, focus on industry, focus on main business, strengthen and optimize, and promote the high-quality development of private economy in Guangdong Province Haiwang Group: 22 Haiwang Group ranks 22nd in the top 100 private enterprises list of Guangdong Province in 2019, and ranks first in the pharmaceutical manufacturing industry of Guangdong Province In 2018, the operating revenue of Haiwang Group was RMB 50321.43 million According to the data, Haiwang Group is a large-scale comprehensive pharmaceutical group company dedicated to pharmaceutical manufacturing, commercial circulation and retail chain Over the years, Haiwang has been insisting on taking the pharmaceutical industry as the core and expanding its business scale It has formed three pillar industrial systems: pharmaceutical industry manufacturing, pharmaceutical retail chain and pharmaceutical commercial circulation Recently, the list of "top 500 enterprises in Shenzhen 2019" was released Among them, Haiwang biology, quanyao.com and Haiwang stars under Haiwang Group are all on the list, ranking 31st, 117th and 127th respectively It is reported that as of this year, Neptune biology has ranked in the top 50 for the 10th consecutive year In addition, on July 10, 2019, fortune Chinese released the list of fortune China's top 500 companies in 2019 Shenzhen Haiwang biology, a listed company of Haiwang Group, ranked 237 with 38.381 billion yuan, up 60 places from last year's ranking, and the ranking was greatly improved Data shows that in 2018, the overall sales revenue of Haiwang bio reached 38.381 billion yuan, including 36.976 billion yuan of main business revenue of pharmaceutical business, an increase of 54.33% year on year Kangmei pharmaceutical: 60 Kangmei pharmaceutical ranked the 60th in the list of top 100 private enterprises in Guangdong Province in 2019, and its business income reached 19356.23 million yuan in 2018 According to the data, Kangmei Pharmaceutical Co., Ltd was founded in 1997 It is a modern large-scale pharmaceutical enterprise with the production of Chinese herbal pieces, chemical raw materials and preparations as its leading role, integrating the production, research and development of drugs and the marketing of drugs and medical devices In Guangdong, Beijing, Shanghai, Sichuan, Jilin, Anhui, Gansu and other places, it has established 17 modern production bases of Chinese herbal pieces and medicine, and has built more than 50 genuine herbal medicine planting bases, which have spread to Yunnan, Guizhou, Jilin, Liaoning, Gansu, Inner Mongolia, Guangdong, Anhui, Hunan and other places Since 2019, Kangmei pharmaceutical industry has continuously increased its efforts to promote the production of Chinese herbal pieces, improve the market share of Chinese herbal medicines, and ensure the timely and quantity guaranteed supply of products At the same time, by standardizing planting, constant temperature storage, intelligent production, online quality control and intelligent pharmacy, the quality control system of the whole industry chain of traditional Chinese medicine has been built to achieve "quality manufacturing" In addition, in 2019, Kangmei Pharmaceutical Co., Ltd also participated in the formulation of 14 standards for commodity specifications and grades of Chinese herbal medicines Two varieties won the title of Chinese herbal medicine brand, 15 won the title of Guangdong herbal medicine brand, and three won the title of Guangdong pharmaceutical brand products Its achievements in the quality of traditional Chinese medicine are remarkable.